OR WAIT null SECS
June 14, 2023
The new excipients manufacturing facility is expected to be completed in 2025.
June 09, 2023
This will allow industry leaders to make and sell the product, in addition to providing more choice to pharma and biotech companies.
June 07, 2023
Domino Data Lab's expanded platform includes a new project hub, additional cloud offerings, and the Model Sentry solution suite.
Under the €35 million (US$37 million) investment, MilliporeSigma will expand its sites in Glasgow and Stirling, Scotland, to increase biosafety testing for drug development and commercialization.
June 06, 2023
Lonza will gain access to R&D capabilities, including payload and site-specific linker technology, through its acquisition of ADC company, Synaffix.
June 05, 2023
Adamis Pharmaceuticals announced the closing of its merger with DMK Pharmaceuticals on May 25, 2023.
June 01, 2023
Through the acquisition, Avacta gains Coris’ product portfolio consisting of diagnostic tests for respiratory, gastroenteric, and blood-borne pathogens as well as for the detection of antibiotic resistance markers.
WuXi Biologics is expanding its manufacturing capacity for drug substance and drug product at its sites in Leverkusen and Wuppertal, Germany.
A partnership between Rentschler Biopharma and Ikarovec will support the accelerated development of novel gene therapies for the treatment of eye diseases.
May 31, 2023
API supplier Olon has started construction of a new manufacturing facility in Milan, Italy, which will be dedicated to production of cytotoxic payloads and linkers for ADCs.